Lobbying

Healthfirst's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.

Healthfirst

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$150K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Healthfirst lobbying by quarter
Healthfirst lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$50K1
Q2 2023$50K1
Q3 2023$50K1
Q4 2023$50K1
Q1 2024$50K1
Q2 2024$50K1
Q3 2024$50K1
Q4 2024$50K1
Q1 2025$50K1
Q2 2025$50K1
Q3 2025$50K1
Q4 2025$50K1
Q1 2026$50K1
Q2 2026$50K1
Q3 2026$00

By issue

  • Medicare and Medicaid$625K · 15 reports
  • Health issues$125K · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health & Human Services, Dept of (HHS)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
Welsh Rose$750K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/08for Q2Welsh Rose$50K
04/08for Q1Welsh Rose$50K
01/16for Q4 2025Welsh Rose$50K
25/10/20for Q3 2025Welsh Rose$50K
25/07/02for Q2 2025Welsh Rose$50K
25/04/16for Q1 2025Welsh Rose$50K
25/01/09for Q4 2024Welsh Rose$50K
24/10/04for Q3 2024Welsh Rose$50K
24/07/19for Q2 2024Welsh Rose$50K
24/04/09for Q1 2024Welsh Rose$50K
24/01/15for Q4 2023Welsh Rose$50K
23/10/04for Q3 2023Welsh Rose$50K
23/07/12for Q2 2023Welsh Rose$50K
23/04/13for Q1 2023Welsh Rose$50K
23/01/13for Q4 2022Welsh Rose$50K